Demo

2161 Articles Matching "price"

Hospital Pricing Practices: Transparency And Clarity Are Lacking

Mar 20, 2019 , Forbes
Since 2015, the average pace of hospital and physician expenditures has exceeded prescription drugs. Legislators are attempting to pry open the black box of hospital costs. Per the 1st of January a new law requires all U.S. hospitals to post complete price lists of all procedures...
Read more

Viewpoints: Thumbs Up To Trump For Trying To Bring Price Transparency To Health Care; FDA Can’t Stray From Shaping Good Scientific Innovation

Mar 20, 2019 , Kaiser Health News
Opinion writers weigh in on these health issues and...
Read more

Medicines Only Work if Patients Can Afford Them: Solutions For The High Drug Prices Era

Mar 19, 2019 , Forbes
New drug therapies help people live longer, better lives. But in a world of increasing health costs, prescribing life-saving medications for our patients isn’t enough. Physicians, health plans and pharmaceutical manufacturers have to ensure that patients can afford to take them, as...
Read more

Report That Finds Sharp Increase In Commercial Health Care Prices Highlights Geographical Differences In Costs

Mar 14, 2019 , Kaiser Health News
"That fact that you could be paying 2.5 times more for the same healthcare services in San Jose than in Baltimore suggests there is a lot of variation in prices across the country," said Bill Johnson, lead author of the report. Meanwhile, Humana launches a bundled-payment model for some Medicare Advantage...
Read more

Insurance Giant UnitedHealthcare Will Require All New Employer-Sponsored Health Plans To Pass Drug Discounts To Consumers

Mar 14, 2019 , Kaiser Health News
Pharmacy benefit managers typically negotiate rebates from pharmaceutical companies to help offset the high initial prices set for many drugs. But those discounts rarely flow directly to consumers. The rebate system has come under intense scrutiny as of late as lawmakers take aim at high drug prices and pharma companies point the blame elsewhere. Meanwhile, the Senate Finance Committee plans to call executives from five pharmacy benefit managers--the middlemen who operate within the rebate...
Read more
A demo

Senate panel asks CVS and four other pharmacy middlemen to testify about drug prices

Mar 13, 2019 , CNBC Health
Senate Finance Committee Chairman Chuck Grassley, R-Iowa., and Ron Wyden, D-Ore., the committee's ranking member, asked Cigna, CVS, Humana, OptumRx and Prime Therapeutics to testify on Capitol Hill on April...
Read more

Hospitals, Health Industry Question Trump Administration’s Legal Authority To Require Price Transparency

Mar 13, 2019 , Kaiser Health News
The Trump administration is considering requiring hospitals and insurers to reveal the true costs of medical services, which have always been tightly held, confidential secrets by the parties involved. The industry says the administration lacks the authority to mandate such disclosures, while also pointing out that they wouldn't do much to help consumers....
Read more

China hog prices hit 14-month high as African swine fever slashes output

Mar 12, 2019 , Reuters
Chinese hog prices marched to their highest in 14 months on Monday and look set to keep rising after weeks of gains, analysts and producers said, as the worst disease outbreak to hit the country's vast pig herd in years chops supply....
Read more

Cities shrug off FDA warning about Canadian drug imports

Mar 08, 2019 , CNN Health
Cities and local governments in several states said they will continue to use a Canadian company to offer employees prescription drugs at a highly reduced price, even though federal officials raised safety concerns about the practice last week....
Read more

Lawmakers United Against High Drug Prices Bare Partisan Teeth

Mar 08, 2019 , Kaiser Health News
Clear differences of opinion emerged between Democrats and Republicans during a House Ways and Means subcommittee hearing about how to make prescription drugs more affordable in the Medicare...
Read more

HHS Secretary Azar's Hospital Price Transparency Plan Is A Terrible Idea Whose Time Has Come

Mar 07, 2019 , Forbes
Last year, a man in Indianapolis went to the hospital with severe abdominal pain. After a series of uncomfortable tests, he was treated, discharged, readmitted and then discharged again. Still, his ordeal wasn’t over. The mail brought new forms of pain: bills and more bills, each one a...
Read more
Banner Health Children

Eli Lilly Offers Lower-Priced Version of its Lispro Insulin

Mar 07, 2019 , RxList
Eli Lilly and Company has announced the launch of a lower-priced version of its lispro (Humalog) insulin in the United...
Read more

Perspectives: Could An All-You-Can-Use Netflix-Like Subscription Model Work To Curb High Drug Prices?

Mar 07, 2019 , Kaiser Health News
Read recent commentaries about drug-cost...
Read more

Americans want lower prescription prices, but not if it means fewer drugs, survey finds

Mar 07, 2019 , CNBC Health
About 90 percent in the poll agree with Trump plans to require drug companies to include list prices in ads and to ease development of generic...
Read more

J&J prices ketamine-like depression treatment at $590-$885 for two doses

Mar 07, 2019 , Reuters
Johnson & Johnson said on Wednesday its nasal spray depression treatment, called Spravato, will be priced at $590 for a 56 mg dose and $885 for 84 mg....
Read more

Health Care Finding Success, Challenges in Consumerism

Mar 07, 2019 , Healthcare Business News
March 5—Providers and health plans have found some success—and identified new challenges—in their efforts to better engage patients as consumers who are willing to choose care based on price and quality....
Read more

Pharma CEOs Brush Off Importance Of List Prices, But Here’s Why They Actually Do Matter To Consumers

Mar 07, 2019 , Kaiser Health News
News outlets report on stories related to pharmaceutical...
Read more

Eli Lilly Offers Lower-Priced Version of Insulin

Mar 07, 2019 , eMedicine Health
Eli Lilly Offers Lower-Priced Version of its Lispro...
Read more

Amid uproar over high drug prices, Eli Lilly introduces generic insulin at half price of brand-name Humalog

Mar 05, 2019 , CNN Health
Pharmaceutical company Eli Lilly will sell a cheaper generic version of its rapid-acting insulin Humalog, according to a statement Monday from Chairman and CEO Dave Ricks....
Read more

Eli Lilly seeks to quell drug price anger with cheaper insulin

Mar 05, 2019 , Reuters
Drugmaker Eli Lilly announced plans on Monday to sell a half-price version of its popular insulin injection Humalog, as it fends off criticism about rising drug prices in the United States....
Read more